Second primary tumor after immune checkpoint inhibitor therapy: A case report

Immune checkpoint inhibitors (ICIs) are used to treat many types of cancers. However, the effect of ICIs on second primary tumors is still unclear. Some studied have concluded that ICIs could reduce the incidence of second primary tumors, while others found an increased overall risk of second primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Kang, Yu, Shuangni, Ni, Jun, Zhang, Xiaotong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977149/
https://www.ncbi.nlm.nih.gov/pubmed/35150077
http://dx.doi.org/10.1111/1759-7714.14327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977149/
https://www.ncbi.nlm.nih.gov/pubmed/35150077
http://dx.doi.org/10.1111/1759-7714.14327

Ejemplares similares